サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1293983

女性の健康診断市場：タイプ別（ポイントオブケア、セルフチェック）、用途別（乳がん検査、子宮頸がん検査、感染症検査）、エンドユーザー別-2023-2030年の世界予測

Women's Health Diagnostics Market by Type (Point-of-Care, Self Check), Application (Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing), End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
女性の健康診断市場：タイプ別（ポイントオブケア、セルフチェック）、用途別（乳がん検査、子宮頸がん検査、感染症検査）、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性の健康診断の世界市場は、2023年に439億5,000万米ドル、CAGR 9.08%で大幅な成長が予測され、2030年には809億1,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の女性の健康診断市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.女性の健康診断の世界市場規模および予測は？

2.予測期間中、世界の女性の健康診断市場を形成するCOVID-19の阻害要因と影響は？

3.女性の健康診断の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.女性の健康診断の世界市場における競争戦略は？

5.女性の健康診断の世界市場における技術動向と規制の枠組みは？

6.女性の健康診断の世界市場における主要ベンダーの市場シェアは？

7.女性の健康診断の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 女性の慢性疾患や生活習慣に関連した疾患の増加
      • ポイントオブケアおよび迅速診断検査の導入
      • 画像診断センターと民間診断センターの利用可能性
    • 抑制要因
      • 処置や画像診断システムに関連する高額な費用
    • 機会
      • 改善され技術的に進歩したヘルスケアインフラ
      • 診断用のマイクロ流体工学およびナノテクノロジーベースのPOCデバイスへの注目の高まり
      • 女性に関連するいくつかのがんの診断に関する臨床試験の評価
    • 課題
      • 技術的に熟練したラボアシスタントが限られている
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 女性の健康診断市場：タイプ別

  • ポイントオブケア
  • セルフチェック

第7章 女性の健康診断市場：用途別

  • 乳がん検査
    • 生検
    • 血液化学および血球数検査
    • 乳がん腫瘍マーカー検査
    • マンモグラフィー
  • 子宮頸がん検査
    • HPV検査
    • PAPスミア
  • 感染症検査
    • 肝炎検査
    • MRSA検査
    • 結核検査
    • 尿路感染症検査（膣pHおよび膣炎）
  • 骨粗鬆症検査
    • 骨密度測定
    • 体外血液検査
  • 卵巣がん検査
    • 画像診断検査
    • 卵巣がん腫瘍マーカー検査
  • 妊娠と生殖能力の検査
    • 妊孕性モニター
    • ラボベースのテスト
    • 妊娠検査薬と排卵予測キット
  • 出生前遺伝子スクリーニングと保因者検査
    • 嚢胞性線維症
    • ダウン症候群とエドワーズ症候群
    • トーチ感染症
  • 性感染症検査
    • クラミジア・トラコマチスおよび淋菌（CT/NG）検査
    • HIV検査
  • 超音波検査
    • 乳房画像検査
    • 産婦人科画像診断

第8章 女性の健康診断市場：エンドユーザー別

  • 診断センターと画像センター
  • ホームケア
  • 病院とクリニック

第9章 南北アメリカの女性の健康診断市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の女性の健康診断市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの女性の健康診断市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. WOMEN'S HEALTH DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 9. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. WOMEN'S HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 9. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES & BLOOD CELL COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 15. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 19. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 29. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING & OVULATION PREDICTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 38. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME & EDWARDS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 47. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE
目次
Product Code: MRR-43477954269D

The Global Women's Health Diagnostics Market is forecasted to grow significantly, with a projected USD 43.95 billion in 2023 at a CAGR of 9.08% and expected to reach a staggering USD 80.91 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Women's Health Diagnostics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Women's Health Diagnostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Point-of-Care and Self Check. The Point-of-Care is projected to witness significant market share during forecast period.

Based on Application, market is studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy & Fertility Testing, Prenatal Genetic Screening & Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests. The Breast Cancer Testing is further studied across Biopsies, Blood Chemistries & Blood Cell Count Tests, Breast Cancer Tumor Marker Tests, and Mammography. The Cervical Cancer Testing is further studied across HPV Testing and PAP Smear. The Infectious Disease Testing is further studied across HEPAtitis Testing, MRSA Testing, Tuberculosis Testing, and Urinary Tract Infection Testing (Vaginal pH & Vaginitis). The Osteoporosis Testing is further studied across Bone Densitometry and in Vitro Blood Tests. The Ovarian Cancer Testing is further studied across Diagnostic Imaging Tests and Ovarian Cancer Tumor Marker Tests. The Pregnancy & Fertility Testing is further studied across Fertility Monitors, Lab-Based Testing, and Pregnancy Testing & Ovulation Prediction Kits. The Prenatal Genetic Screening & Carrier Testing is further studied across Cystic Fibrosis, Down Syndrome & Edwards Syndrome, and Torch Infections. The Sexually Transmitted Disease Testing is further studied across Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing and HIV Testing. The Ultrasound Tests is further studied across Breast Imaging and OB/GYN Imaging. The Osteoporosis Testing is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Diagnostic & Imaging Centers, Home Care, and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Women's Health Diagnostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Women's Health Diagnostics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Women's Health Diagnostics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Women's Health Diagnostics Market?

4. What is the competitive strategic window for opportunities in the Global Women's Health Diagnostics Market?

5. What are the technology trends and regulatory frameworks in the Global Women's Health Diagnostics Market?

6. What is the market share of the leading vendors in the Global Women's Health Diagnostics Market?

7. What modes and strategic moves are considered suitable for entering the Global Women's Health Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Women's Health Diagnostics Market, by Type, 2022 vs 2030
  • 4.3. Women's Health Diagnostics Market, by Application, 2022 vs 2030
  • 4.4. Women's Health Diagnostics Market, by End-User, 2022 vs 2030
  • 4.5. Women's Health Diagnostics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing instances of chronic and life style- related disorders in women
      • 5.1.1.2. Adoption of point-of-care and rapid diagnostic tests
      • 5.1.1.3. Availability of imaging and private diagnostic centres
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with procedures and diagnostic imaging system
    • 5.1.3. Opportunities
      • 5.1.3.1. Improved and technically advanced healthcare infrastructure
      • 5.1.3.2. Growing focus on microfluidics and nanotechnology-based POC devices for diagnostic
      • 5.1.3.3. Clinical trial assessment for the diagnosis of several cancer's associated with the women
    • 5.1.4. Challenges
      • 5.1.4.1. Limited technically skilled lab assistants
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Women's Health Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Point-of-Care
  • 6.3. Self Check

7. Women's Health Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Breast Cancer Testing
    • 7.2.1. Biopsies
    • 7.2.2. Blood Chemistries & Blood Cell Count Tests
    • 7.2.3. Breast Cancer Tumor Marker Tests
    • 7.2.4. Mammography
  • 7.3. Cervical Cancer Testing
    • 7.3.1. HPV Testing
    • 7.3.2. PAP Smear
  • 7.4. Infectious Disease Testing
    • 7.4.1. HEPAtitis Testing
    • 7.4.2. MRSA Testing
    • 7.4.3. Tuberculosis Testing
    • 7.4.4. Urinary Tract Infection Testing (Vaginal pH & Vaginitis)
  • 7.5. Osteoporosis Testing
    • 7.5.1. Bone Densitometry
    • 7.5.2. in Vitro Blood Tests
  • 7.6. Ovarian Cancer Testing
    • 7.6.1. Diagnostic Imaging Tests
    • 7.6.2. Ovarian Cancer Tumor Marker Tests
  • 7.7. Pregnancy & Fertility Testing
    • 7.7.1. Fertility Monitors
    • 7.7.2. Lab-Based Testing
    • 7.7.3. Pregnancy Testing & Ovulation Prediction Kits
  • 7.8. Prenatal Genetic Screening & Carrier Testing
    • 7.8.1. Cystic Fibrosis
    • 7.8.2. Down Syndrome & Edwards Syndrome
    • 7.8.3. Torch Infections
  • 7.9. Sexually Transmitted Disease Testing
    • 7.9.1. Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing
    • 7.9.2. HIV Testing
  • 7.10. Ultrasound Tests
    • 7.10.1. Breast Imaging
    • 7.10.2. OB/GYN Imaging

8. Women's Health Diagnostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic & Imaging Centers
  • 8.3. Home Care
  • 8.4. Hospitals & Clinics

9. Americas Women's Health Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Health Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. Abbott Laboratories

2. AccuBioTech Co., Ltd.

3. Alere Inc.

4. Becton, Dickinson and Company

5. Biomerieux SA

6. Cardinal Health, Inc.

7. Carestream Health, Inc.

8. Chembio Diagnostic Systems, Inc.

9. Cook Medical, Inc.

10. Danaher Corporation

11. DIALAB GmbH

12. EKF Diagnostics Holdings plc

13. F. Hoffmann-La Roche Ltd.

14. FUJIFILM Holdings Corporation

15. GE Healthcare

16. Guided Therapeutics, Inc.

17. Hologic, Inc.

18. Koninklijke Philips N.V.

19. MedGyn Products, Inc.

20. NeuroLogica Corporation

21. Nova Biomedical

22. Osteometer MediTech, Inc.

23. Perkinelmer Inc.

24. Quest Diagnostics Incorporated

25. Siemens AG

26. SuperSonic Imagine

27. WerfenLife, S.A.